Total Payments
$407.33
2024 Payments
$14.68
Companies
6
Transactions
26
Medicare Patients
219
Medicare Billing
$16,145
Payment Breakdown by Category
Food & Beverage$407.33 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $407.33 | 26 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $136.50 | 9 | $0 (2023) |
| Lilly USA, LLC | $107.13 | 7 | $0 (2024) |
| AbbVie Inc. | $62.56 | 4 | $0 (2023) |
| Exact Sciences Corporation | $44.79 | 2 | $0 (2023) |
| PFIZER INC. | $43.09 | 3 | $0 (2023) |
| Astellas Pharma US Inc | $13.26 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $14.68 | 1 | Lilly USA, LLC ($14.68) |
| 2023 | $317.02 | 20 | Novo Nordisk Inc ($90.37) |
| 2022 | $59.21 | 4 | Novo Nordisk Inc ($29.71) |
| 2020 | $16.42 | 1 | Novo Nordisk Inc ($16.42) |
All Payment Transactions
26 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 01/04/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Food and Beverage | In-kind items and services | $14.68 | General |
| Category: Obesity | ||||||
| 12/13/2023 | PFIZER INC. | PAXLOVID (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $16.04 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 12/11/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $23.05 | General |
| Category: Oncology | ||||||
| 12/04/2023 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $13.61 | General |
| Category: VACCINES | ||||||
| 11/16/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $15.75 | General |
| Category: Diabetes | ||||||
| 10/26/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $13.26 | General |
| Category: Biological | ||||||
| 10/16/2023 | AbbVie Inc. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $17.34 | General |
| Category: NEUROSCIENCE | ||||||
| 08/31/2023 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $14.70 | General |
| 08/30/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $13.79 | General |
| Category: Diabetes | ||||||
| 08/09/2023 | AbbVie Inc. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $13.14 | General |
| Category: NEUROSCIENCE | ||||||
| 07/26/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $16.88 | General |
| Category: Diabetes | ||||||
| 06/28/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $14.82 | General |
| Category: Diabetes | ||||||
| 06/21/2023 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $13.44 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 06/12/2023 | AbbVie Inc. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $15.70 | General |
| Category: NEUROSCIENCE | ||||||
| 06/05/2023 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $17.14 | General |
| 05/17/2023 | Lilly USA, LLC | EMGALITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $15.40 | General |
| Category: Neuroscience | ||||||
| 05/15/2023 | AbbVie Inc. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $16.38 | General |
| Category: NEUROSCIENCE | ||||||
| 05/01/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $21.74 | General |
| Category: Oncology | ||||||
| 04/03/2023 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $14.73 | General |
| 03/15/2023 | Lilly USA, LLC | TRULICITY (Drug), MOUNJARO | Food and Beverage | In-kind items and services | $16.88 | General |
| Category: Diabetes | ||||||
| 01/30/2023 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $13.23 | General |
| 12/05/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $13.90 | General |
| Category: Diabetes | ||||||
| 11/09/2022 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $15.81 | General |
| 10/26/2022 | Lilly USA, LLC | EMGALITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $15.56 | General |
| Category: Neuroscience | ||||||
| 10/19/2022 | Lilly USA, LLC | TRULICITY (Drug), MOUNJARO | Food and Beverage | In-kind items and services | $13.94 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 54 | 71 | $20,959 | $6,922 |
| 2022 | 5 | 165 | 167 | $32,140 | $9,222 |
Total Patients
219
Total Services
238
Medicare Billing
$16,145
Procedure Codes
9
All Medicare Procedures & Services
9 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 12 | 19 | $7,505 | $2,470 | 32.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 17 | 25 | $7,025 | $2,073 | 29.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 12 | 12 | $3,444 | $1,650 | 47.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 13 | 15 | $2,985 | $728.99 | 24.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 94 | 94 | $25,755 | $6,777 | 26.3% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2022 | 29 | 29 | $2,151 | $887.34 | 41.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 11 | 11 | $3,252 | $836.94 | 25.7% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2022 | 16 | 16 | $880.00 | $663.24 | 75.4% |
| 81002 | Urinalysis, manual test | Office | 2022 | 15 | 17 | $102.00 | $58.47 | 57.3% |
About Dr. Raleke Adibe, DO
Dr. Raleke Adibe, DO is a Family Medicine healthcare provider based in Somerdale, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/25/2017. The National Provider Identifier (NPI) number assigned to this provider is 1477081156.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Raleke Adibe, DO has received a total of $407.33 in payments from pharmaceutical and medical device companies, with $14.68 received in 2024. These payments were reported across 26 transactions from 6 companies. The most common payment nature is "Food and Beverage" ($407.33).
As a Medicare-enrolled provider, Adibe has provided services to 219 Medicare beneficiaries, totaling 238 services with total Medicare billing of $16,145. Data is available for 2 years (2022–2023), covering 9 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Somerdale, NJ
- Active Since 05/25/2017
- Last Updated 09/23/2022
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1477081156
Products in Payments
- QULIPTA (Drug) $62.56
- Cologuard Collection Kit (Device) $44.79
- Rybelsus (Drug) $44.47
- EMGALITY (Drug) $30.96
- TRULICITY (Drug) $30.82
- MOUNJARO (Drug) $30.67
- PAXLOVID (Drug) $29.48
- Tresiba (Drug) $16.42
- ZEPBOUND (Drug) $14.68
- PREVNAR 20 (Biological) $13.61
- Veozah (Drug) $13.26
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.